Oxcarbazepine
NDC 69452-125, Oxcarbazepine, suspension, from Bionpharma Inc..
- Product NDC
- 69452-125
- Status
- Listed
- Labeler
- Bionpharma Inc.
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA209652
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69452-125 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OXCARBAZEPINE300 mg/5mL
Pharmacologic classes
Anti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69452-125-50 | 69452012550 | 1 BOTTLE, GLASS in 1 CARTON (69452-125-50) / 250 mL in 1 BOTTLE, GLASS |
| 69452-125-51 | 69452012551 | 1 BOTTLE, PLASTIC in 1 CARTON (69452-125-51) / 250 mL in 1 BOTTLE, PLASTIC |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/ec033897-21b4-4d08-83de-042783e89251NADAC price for package 69452012550
GET /v1/drugs/nadac/69452012550NADAC price for package 69452012551
GET /v1/drugs/nadac/69452012551
Use it
Look up 69452-125 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69452-125 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69452-125. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.